TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
TetraLogic Pharma (TLOG) Misses Q4 EPS by 14c
February 26, 2015 4:56 PM ESTTetraLogic Pharma (NASDAQ: TLOG) reported Q4 EPS of ($0.53), $0.14 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on TetraLogic Pharma (TLOG) click here.
... More